People over 50, rejoice! The FDA has approved a non-invasive test for colorectal cancer, and it may not take years to obtain. Mayo Clinic gastroenterologist David Ahlquist co-invented the test, Cologuard, which detects the presence of ...
Exact Sciences has submitted the second module of premarket application (PMA) of its noninvasive stool DNA colorectal cancer screening test to the US Food and Drug Administration (FDA). The module included the required studies and ...
Tags: FDA, colorectal cancer, clinical trial
Exact Sciences has completed enrolling patients in its DeeP-C pivotal trial, designed to compare the accuracy of the stool DNA test in screening colorectal cancer with traditional screening methods. The test uses stool samples collected ...
Tags: Exact Sciences, DeeP-C pivotal trial, colorectal cancer
Molecular diagnostics company Exact Sciences has submitted to the US Food and Drug Administration(FDA)the first module of the premarket approval(PMA)application for its stool DNA colorectal cancer screening test. The first modular ...
Tags: molecular diagnostics, Exact Sciences, PMA application